- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05846256
Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment
April 26, 2023 updated by: Peter Humaidan
Evaluation of Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment
The aim of this study is to investigate the extent of double-stranded DNA damage in sperm in men with unexplained infertility.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
125
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Peter Humaidan, Professor
- Phone Number: 78445760
- Email: peter.humaidan@midt.rm.dk
Study Contact Backup
- Name: Mette Jensen, Research assistant
- Phone Number: 78445718
- Email: mejen8@rm.dk
Study Locations
-
-
-
Skive, Denmark, 7800
- Recruiting
- Fertility Clinic Regional Hospital Skive
-
Contact:
- Birgit Alsbjerg, M.D.
- Phone Number: +45 78 44 57 60
- Email: birgit.alsbjerg@midt.rm.dk
-
Contact:
- Alice Mikkelsen
- Email: Alice.Toft.Mikkelsen@midt.rm.dk
-
Principal Investigator:
- Birgit Alsbjerg, M.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Men with unexplanied infertility undergoing fertility treatment
Description
Inclusion Criteria:
- Unexplained infertile men who will undergo 1st or 2nd IVF treatment
- Age over 18 years
- Normal sperm parameters according to WHO criteria
- IVF treatment
Exclusion Criteria:
- ICSI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Infertile male
Men with unexplained infertility
|
Sperm DNA Fragmentation analysis.
|
Donors (control)
Fertile sperm donors
|
Sperm DNA Fragmentation analysis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The proportion of double-stranded DNA damage in sperm of men with unexplained infertility.
Time Frame: 30-60 minutes
|
Sperm DNA Fragmentation done with a Comet Assay analysis
|
30-60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The proportion of single-stranded DNA damage in sperm of men with unexplained infertility
Time Frame: 30-60 minutes
|
Sperm DNA Fragmentation done with a Comet Assay analysis
|
30-60 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 25, 2023
Primary Completion (Anticipated)
May 1, 2024
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
April 26, 2023
First Submitted That Met QC Criteria
April 26, 2023
First Posted (Estimate)
May 5, 2023
Study Record Updates
Last Update Posted (Estimate)
May 5, 2023
Last Update Submitted That Met QC Criteria
April 26, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Doublestrand DNA Fragmentation
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility, Male
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Reproductive Medicine Associates of New JerseyTerminated
-
Jinling Hospital, ChinaRecruitingMale Infertility Due to HypospermatogenesisChina
-
Sapientiae InstituteTerminated
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Hillel Yaffe Medical CenterUnknownMale Infertility With Severe Oligo-terato-asteno-spermiaIsrael
-
Assiut UniversityNot yet recruitingMale Infertility Due to Azoospermia
-
Universitair Ziekenhuis BrusselRecruitingMale InfertilityBelgium
Clinical Trials on Sperm DNA Fragmentation
-
Origin SciencesRoyal Infirmary of EdinburghRecruitingDiagnosis | Vagina DiseaseUnited Kingdom
-
University Hospital, AntwerpUniversiteit AntwerpenCompletedDNA Damage | Infertility, Male | Infertility UnexplainedBelgium
-
Assiut UniversityCompleted
-
University of TurkuTurku University HospitalEnrolling by invitationMyocardial Infarction | Myocardial InjuryFinland
-
Hamad Medical CorporationFairhaven HealthUnknownInfertility, Male | Antioxidants | Semen QualityQatar
-
CREA Medicina de la Reproducción SLRecruitingIntracytoplasmic Sperm Injection | Sperm | MicrofluidicsSpain
-
Oogziekenhuis RotterdamCarl Zeiss Meditec AG; Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis...RecruitingNuclear CataractNetherlands
-
Royan InstituteCompletedInfertilityIran, Islamic Republic of
-
Equipo Juana CrespoUnknownIVF | Premature Ovarian Failure | Ovarian FailureSpain
-
Fondation Ophtalmologique Adolphe de RothschildTerminated